Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergey Yurasov

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Current Opinion in Rheumatology|September 1, 2007
Regulation of autoreactive antibodiesSergey Yurasov, Michel C Nussenzweig
Annals of the New York Academy of Sciences|February 8, 2006
B-cell tolerance checkpoints in healthy humans and patients with systemic lupus erythematosusSergey Yurasov, Johanna Hammersen, Thomas Tiller, et al.
Journal of Immunological Methods|November 13, 2007
Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloningThomas Tiller, Eric Meffre, Sergey Yurasov, et al.
The Journal of Experimental Medicine|February 1, 2006
A checkpoint for autoreactivity in human IgM+ memory B cell developmentMakoto Tsuiji, Sergey Yurasov, Klara Velinzon, et al.
Immunity|February 20, 2007
Autoreactivity in human IgG+ memory B cellsThomas Tiller, Makoto Tsuiji, Sergey Yurasov, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2011
Differential regulation of self-reactivity discriminates between IgG+ human circulating memory B cells and bone marrow plasma cellsJohannes F Scheid, Hugo Mouquet, Juliane Kofer, et al.
Clinical Lung Cancer|August 3, 2012
A randomized, double-blind, phase III study of Docetaxel and Ramucirumab versus Docetaxel and placebo in the treatment of stage IV non-small-cell lung cancer after disease progression after 1 previous platinum-based therapy (REVEL): treatment rationale and study designEdward B Garon, Dachuang Cao, Ekaterine Alexandris, et al.
Science (New York, N.Y.)|August 16, 2003
Predominant autoantibody production by early human B cell precursorsHedda Wardemann, Sergey Yurasov, Anne Schaefer, et al.
The Journal of Experimental Medicine|September 13, 2006
Persistent expression of autoantibodies in SLE patients in remissionSergey Yurasov, Thomas Tiller, Makoto Tsuiji, et al.
The Journal of Experimental Medicine|March 2, 2005
Defective B cell tolerance checkpoints in systemic lupus erythematosusSergey Yurasov, Hedda Wardemann, Johanna Hammersen, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Opinion in Rheumatology|September 1, 2007
Regulation of autoreactive antibodiesSergey Yurasov, Michel C Nussenzweig
Annals of the New York Academy of Sciences|February 8, 2006
B-cell tolerance checkpoints in healthy humans and patients with systemic lupus erythematosusSergey Yurasov, Johanna Hammersen, Thomas Tiller, et al.
Journal of Immunological Methods|November 13, 2007
Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloningThomas Tiller, Eric Meffre, Sergey Yurasov, et al.
The Journal of Experimental Medicine|February 1, 2006
A checkpoint for autoreactivity in human IgM+ memory B cell developmentMakoto Tsuiji, Sergey Yurasov, Klara Velinzon, et al.
Immunity|February 20, 2007
Autoreactivity in human IgG+ memory B cellsThomas Tiller, Makoto Tsuiji, Sergey Yurasov, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2011
Differential regulation of self-reactivity discriminates between IgG+ human circulating memory B cells and bone marrow plasma cellsJohannes F Scheid, Hugo Mouquet, Juliane Kofer, et al.
Clinical Lung Cancer|August 3, 2012
A randomized, double-blind, phase III study of Docetaxel and Ramucirumab versus Docetaxel and placebo in the treatment of stage IV non-small-cell lung cancer after disease progression after 1 previous platinum-based therapy (REVEL): treatment rationale and study designEdward B Garon, Dachuang Cao, Ekaterine Alexandris, et al.
Science (New York, N.Y.)|August 16, 2003
Predominant autoantibody production by early human B cell precursorsHedda Wardemann, Sergey Yurasov, Anne Schaefer, et al.
The Journal of Experimental Medicine|September 13, 2006
Persistent expression of autoantibodies in SLE patients in remissionSergey Yurasov, Thomas Tiller, Makoto Tsuiji, et al.
The Journal of Experimental Medicine|March 2, 2005
Defective B cell tolerance checkpoints in systemic lupus erythematosusSergey Yurasov, Hedda Wardemann, Johanna Hammersen, et al.
Pageof 2